Adaptyx Biosciences
PrivateLast Round
Seed
Oct 20, 2025
Total Funding Raised
$14M
Company Overview
Adaptyx Biosciences operates in Healthcare & Life Sciences and is based in Menlo Park, California. Its latest recorded funding round was a Seed round in October 2025.
Adaptyx Biosciences is a biotechnology company that develops a biowearable platform for continuous, multi-analyte molecular monitoring using synthetic DNA-based molecular switches and AI-powered analytics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Data as a Service
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adaptyx Biosciences Comparables
Compare Adaptyx Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Level Zero Health | 87% | |
| Aptec Health | 83% | |
| Nutromics | 82% |
For institutional investors. Book with your work email.
Adaptyx Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Adaptyx Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Interlagos Capital | Seed |
| Starbloom Capital | Seed |
| Cantos Ventures | Seed |
| Stanford University | Seed |
| Humba Ventures | Seed |
| Seaside Ventures | Seed |
| Hyperlink Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 22, 2025
Grew 30% QoQ, from 10 to 13 employees.
- Oct 22, 2025
Developing a wearable patch for continuous biomarker monitoring.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardSep 9, 2026
Adaptyx Biosciences, Inc. wins first place in the American Diabetes Association's 2026 Innovation Challenge during the 86th Scientific Sessions in Louisiana on Sep 9th '26.
- is_developingSep 9, 2026
Adaptyx Biosciences, Inc. initially develops a wearable continuous cortisol monitor as part of a biosensing platform designed to continuously measure biochemical signals beyond glucose, with adrenal and cardiometabolic diseases among its clinical areas of focus.
- recognized_asSep 9, 2026
Adaptyx Biosciences, Inc. earns first place in the American Diabetes Association's 2026 Innovation Challenge during the ADA's 86th Scientific Sessions in Louisiana on Sep 9th '26.
For institutional investors. Book with your work email.
Adaptyx Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Adaptyx Biosciences's valuation, stock price, and market status.
Is Adaptyx Biosciences a public or private company?
Adaptyx Biosciences is a private company.
What is the current stock price of Adaptyx Biosciences?
Adaptyx Biosciences is a private company, so its shares have no public market price. Caplight tracks Adaptyx Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Adaptyx Biosciences worth (valuation)?
Valuation information for Adaptyx Biosciences is not publicly available.
Can I buy Adaptyx Biosciences stock?
Adaptyx Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Adaptyx Biosciences's last funding round?
Adaptyx Biosciences's most recent funding round was Seed on October 20, 2025.
Who are the main investors in Adaptyx Biosciences?
Key investors in Adaptyx Biosciences include Interlagos Capital.
Will Adaptyx Biosciences IPO soon?
No public IPO plans have been announced for Adaptyx Biosciences.
How can I track Adaptyx Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Adaptyx Biosciences's shares on secondary markets.